Nuzenio

Tipranks Agios

Tipranks Agios news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 05:38:00 GMTAgios: Buy Rating Reiterated on Strong AQVESME Uptake and Pipeline Progress, Price Target Maintained at $46 - tipranks.comtipranks.com · Sun, 02 Aug 2026 14:40:05 GMTAgios Pharmaceuticals price target raised to $52 from $46 at Citi - tipranks.comtipranks.com · Fri, 31 Jul 2026 10:57:16 GMT

Timeline

Wed, 05 Aug 2026 05:38:00 GMTAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS) - The Globe and Mail
Sun, 02 Aug 2026 14:40:05 GMTAgios: Buy Rating Reiterated on Strong AQVESME Uptake and Pipeline Progress, Price Target Maintained at $46 - tipranks.com
Fri, 31 Jul 2026 10:57:16 GMTAgios Pharmaceuticals price target raised to $52 from $46 at Citi - tipranks.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Agios.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.